Pregnolia

Zurich, Switzerland Founded: 2015 • Age: 11 yrs
Preterm birth risks are predicted using cervical stiffness measurement devices.
Request Access

About Pregnolia

Pregnolia is a company based in Zurich (Switzerland) founded in 2015.. Pregnolia has raised $10.23 million across 10 funding rounds from investors including Zurcher Kantonalbank, European Union and CADFEM. Pregnolia offers products and services including Pregnolia System. Pregnolia operates in a competitive market with competitors including Sera Prognostics, Mirvie, Yourgene Health, NX Prenatal and Rea Diagnostics, among others.

  • Headquarter Zurich, Switzerland
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pregnolia Ag
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $10.23 M (USD)

    in 10 rounds

  • Latest Funding Round
    $2.49 M (USD), Series A

    Nov 21, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Pregnolia

Pregnolia offers a comprehensive portfolio of products and services, including Pregnolia System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Measures cervical stiffness to assess premature birth risk.

People of Pregnolia
Headcount 10-50
Employee Profiles 9
Board Members and Advisors 2
Employee Profiles
People
Laura Bernardi
Product Manager/Clinical & Medical Project Manager
People
Heike Krug
Application Specialist, Germany
People
Francisco Delgado
Founder & VP, R&D
People
Ralph Rechsteiner
Biomedical Engineer

Unlock access to complete

Board Members and Advisors
people
Marc Kohler
Member of the Board
people
Bruno Reihl
Member of the Board

Unlock access to complete

Funding Insights of Pregnolia

Pregnolia has successfully raised a total of $10.23M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $2.49 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 10
  • Last Round Series A — $2.5M
  • First Round

    (01 Dec 2017)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2023 Amount Series A - Pregnolia Valuation

investors

Dec, 2021 Amount Grant - Pregnolia Valuation

investors

Nov, 2020 Amount Grant - Pregnolia Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Pregnolia

Pregnolia has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Zurcher Kantonalbank, European Union and CADFEM. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Venture capital firm focused on science and tech-driven startups
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Pregnolia

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Pregnolia

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Pregnolia Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Pregnolia

Pregnolia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sera Prognostics, Mirvie, Yourgene Health, NX Prenatal and Rea Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Sera Prognostics is focused on women's health diagnostics.
domain founded_year HQ Location
Non-invasive blood tests for prenatal fetal health predictions are offered.
domain founded_year HQ Location
Non-invasive prenatal genetic tests and genomic services are provided.
domain founded_year HQ Location
Early warning blood tests for pregnancy complications are provided.
domain founded_year HQ Location
Wearable diagnostic device is provided to monitor preterm birth risks.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Pregnolia

Pregnolia’s CHF2.2 Million Financing Round
Globallegalchronicle2 years ago
Pregnolia closes seed round
Startupticker7 years ago

Frequently Asked Questions about Pregnolia

When was Pregnolia founded?

Pregnolia was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Where is Pregnolia located?

Pregnolia is headquartered in Zurich, Switzerland.

Is Pregnolia a funded company?

Pregnolia is a funded company, having raised a total of $10.23M across 10 funding rounds to date. The company's 1st funding round was a Grant of $190.11K, raised on Dec 01, 2017.

What does Pregnolia do?

Pregnolia was founded in 2015 in Zurich, Switzerland, within the medical device sector. A flagship product featuring an intra-vaginal probe is offered to assess cervical stiffness, a parameter linked to preterm birth diagnosis. Clinical validation of the device is ongoing. Operations focus on healthcare technology for maternal health, with emphasis on predictive diagnostics in European markets.

Who are the top competitors of Pregnolia?

Pregnolia's top competitors include Mirvie, NX Prenatal and Yourgene Health.

What products or services does Pregnolia offer?

Pregnolia offers Pregnolia System.

Who are Pregnolia's investors?

Pregnolia has 5 investors. Key investors include Zurcher Kantonalbank, European Union, CADFEM, EIC Fund, and Verve Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available